1. Introduction
Hepatitis B is a known killer infectious disease caused by the Hepatitis B virus (HBV), which attacks the liver cells (Hepatocyte), resulting in changes in the antigen structure of the surface of the liver cells, thus, leading to attack and destruction by a mechanism called ‘self-mediated immune damage’.
Although “recovered” patients have lifetime protective immunity, tiny levels of HBV DNA can still be discovered occasionally. These traces of HBV DNA are infectious and stimulate HBV-specific B- and T-cell responses, which control viremia [
1]. However, HBV replication is strongly suppressed by the antiviral effects of inflammatory cytokines generated by HBV-specific
T lymphocytes when they detect the antigen in the infected or transgenic liver, as shown in chimpanzee [
2] and transgenic mouse [
3].
Hepatitis B infection is in two phases; acute and chronic. The acute stage is the earliest stage of the infection whereby the body can recover by its immune system within six
months. The acute infection stage might be asymptotic and characterized by viral replication. Loss of appetite, joint and muscle discomfort, low-grade fever, and potential stomach aches are all signs of an acute infection. Recovery from acute HBV infection means that the virus is no longer in the bloodstream, but inactive in the liver. However, if one uses immune-suppressing drugs, the virus in your liver might be reactivated in the future. HBV replicates only within the host cell since it lacks the enzymes necessary for protein and nucleic acid synthesis [
4]. Chronic HBV infection occurs when the virus is still detectable six months after the infection, indicating that the virus has not been fully cleared by the immune system and is still present in the patient’s blood and liver. The majority of patients with chronic infections are asymptomatic. HBV is transmitted from an infected person to an uninfected person through sexual transmission, child-birth relation, misuse of contaminated needles such as syringes, exchange of infected body fluids such as blood, saliva, menstrual, seminal, and vaginal fluid [
5].
It is also well-known that infected people do not always show symptoms in the early stages, although some may experience an acute illness that lasts several weeks, including Jaundice (yellowing of the skin and eye), dark urine, and extreme fatigue, nausea, vomiting, and some abdominal pains. Despite the above symptoms mentioned, symptoms exhibited by patients also depend on the status of the immune system of the patient, the age, and general health of the patient [
4].
Due to the severity of hepatitis B infection, it has intrigued many scientists and researchers to investigate the dynamics of HBV. In [
6], a spatio-temporal dynamics of a fractional model for HBV infection with cellular immunity was proposed. A time-fractional diffusion model for HBV infection with capsids and Cytotoxic T lymphocytes (CTL) immune response and were able to show that the diffusion and the order of fractional derivatives in the sense of Caputo do not affect the stability of the equilibria, but they can affect the time to arrive at the equilibria. When the order of the fractional derivative increases, for example, the model’s solutions converge quickly to the equilibrium points.
In [
7], the authors looked at a fractional-order HBV immunological model’s global analysis and simulation. Using the Lyapunov function to prove the model’s stability, they derived basic reproduction numbers and presented their relationship with the corresponding equilibria. Studying the hepatitis B virus, the authors in [
8] incorporated the immune response and took into account both cytolytic and noncytolytic effect pathways. The dynamics of immune response to hepatitis B, which takes into account contributions from innate and adaptive immune responses, as well as cytokines, has also been studied, see, [
9].
In this article, we consider an HBV model with a Holling type 2 functional response rate and three (3) compartments, i.e., healthy hepatocytes (H), infected hepatocytes (I), and the body’s immune response (R). We study the existence and uniqueness of the solutions and the equilibrium states, i.e., virus-free and endemic equilibrium state. When the virus present in the liver cells exceeds the cytokines, the virus will overcome the cytokines and multiply in the body, resulting in an endemic state where the virus comes to stay in the body. When cytokines outnumber the viruses in the body, the viruses are cleared from the body, and the person is virus-free.
The rest of the paper is organized as follows;
Section 2 presents preliminary results for fractional calculus. We present the fractional order model and the analysis in
Section 3. In
Section 4, we present the local and global stability analysis. The numerical results and simulations are presented in
Section 5. Finally, we present the conclusions in
Section 6.
3. Fractional Order Model Derivation and Analysis
We consider a liver consisting of Healthy Hepatocyte
Infected hepatocytes
, and immune response-dependent cytotoxic cells
We assume a logistic growth of healthy hepatocytes, see, e.g., [
12,
13]. Healthy Hepatocytes of the liver are known to have half-lives of more than six months; see, [
14]. In the presence of the Hepatitis B virus, we assume that the rate at which hepatocytes become infected is proportional to
Given
as the contact rate and assuming that infected hepatocytes die at a rate
the dynamic model for the infected hepatocytes and the immune response can be described as
with the initial conditions
and
where
and
are the rates of deactivation of virons and cytotoxic cells, respectively. Let
be the rate of production of cytotoxic cells, and
be the baseline degradation rate. We note that the immune response of the cytotoxic cells to the viral invasion was included via a positive feedback mechanism, with a response term
which is a saturating function of the amount of virus present, the full description of the parameters can be seen in
Table 1. Following [
15,
16], the fractional order model of the mathematical model (
4) is given by Caputo derivativeas follows
subject to the initial conditions
and
where
denotes Caputo fractional derivative with the order of the derivative
3.1. Qualitative Properties
Here, we study the well-posedness of the fractional order model. By means of a Banach contraction mapping, we the existence and uniqueness of the solutions.
Let
and
where,
The dynamical system (
5) can be written as,
which is equivalent to (
6). The fractional model has integral representation,
As a result, we show that the fractional model is bounded and positive as long as positive initial conditions are provided. By using the integral representation (
8), we present an analysis of the model. We consider a Banach space,
of all continuous functions from
to
i.e.,
endowed with the norm,
Moreover,
. Let us consider a well-defined operator
such that
3.2. Positivity and Boundedness of Solution
The model (
5) will be biologically meaningful given that the solution of the system with non-negative initial conditions will remain non-negative for any given time
. This is true for this model, given that the theorem below is satisfied.
Theorem 1. Let then for the solution of system is bounded and remains positive for
Proof. Let us consider the trajectory of solution along
H-axis where
and
Given,
We know from (
8) that Equation (
10) can be expressed as,
By using
and applying the beta-gamma relations, we obtain,
Similar arguments as above yields
where
and
yielding non-negative invariance on all axes. Considering a positive solution in the
plane such that for some
we have
and
and
In the
plane,
Thus, we obtain
by the mean value theorem for the Caputo-fractional order derivative Lemma 2 which is a contradiction to our earlier statement. □
For the boundedness of the solution, we show that the model and solution are continuous and exist within a given closed interval or region .
Theorem 2. The model (5) has solutions bounded within the invariant region given by Proof. Since
is the total Population, it follows from Theorem 1 that
Using (
11) and (
12), we obtain,
By taking limits of both sides, we have
□
3.3. Existence and Uniqueness of the Solution
We demonstrate that there is a solution to the model (
5), i.e., the model is mathematically and biologically consistent. To prove this, we use the lemma below.
Lemma 3. Let . The function defined above satisfies ≤ for some .
Proof. and
R are all dependent on
t and from the first component of
see (
6) we observe that,
where
Grouping constant terms and simplifying (
13) we obtain,
where
with
and
Similarly, we do same for second equation in (
6) and we get,
where
with
and finally, we can express,
where
with
and
Finally, we obtain,
and
□
Next, we show that the solution to the model problem exists and is unique using the Banach contraction mapping and follows the technique from [
17].
Theorem 3. Let the result of Lemma 3 hold and let If then there exist a unique solution of model (5) on . Proof. By Banach contraction mapping, we will show that
is both a self-map and a contraction. By definition,
and let
and a close convex set
. In the case of the self-map property, it is sufficient to demonstrate that
so let
then
where
Thus
and
is a self-map. Next, we show that
is a contraction.
If then is a contraction mapping, and thus, there exists a unique fixed point on via Banach contraction principle. □
The existence of the solution follows from Schauder’s fixed point theorem.
Lemma 4. Let such thatsuch that Then, the operator is completely continuous. Proof. For all
we obtain
Thus,
is uniformly bounded. Next, we show that
is equicontinuous. Let
such that
and
then
Thus, is equicontinuous. It is completely continuous as a result of the Arzelá-Ascoli theorem. □
4. Equilibrium Points and Basic Reproduction Number
The model (
5) has a virus-free equilibrium (VFE) obtained by setting the right-hand side of (
5) to zero. Using the next-generation matrix method, the new virus terms and the remaining transfer terms are given by
The effective basic reproduction number is given by
where
denotes the spectral radius,
and
Next, we consider other equilibrium points,
. Here, we consider the case where there are no healthy Hepatocytes, i.e., we equate the right-hand side of (
5) to zero, and assume
in the model (
5) yielding
From (
17), we have
By substituting and simplifying, we have
The final equilibrium point is given by
Again, we set the right-hand side of (
5) to zero yielding,
The second equation of (
5) yields
Since
is non-zero, we have
Finally, the last equation of (
5) yields
4.1. Local Stability Analysis
Here, we present the local stability analysis of the model.
4.1.1. Local Stability of VFE Point
At this stage, we assume there is no viral infection of the Hepatocytes, i.e., the person is virus free. Following [
18], we present the local stability of the virus-free equilibrium in the following theorem.
Theorem 4. The virus-free equilibrium point of the fractional model is locally asymptotically stable (LAS) if , and unstable if .
Proof. The local stability analysis of the VFE is determined by using the eigenvalues of the Jacobian of (
5) given by
Evaluating the Jacobian matrix
at the VFE point
yields,
The eigenvalues of the Jacobian matrix determine an equilibrium’s local stability where the eigenvalues are (
) and
.
The virus-free equilibrium is locally stable, given that all the eigenvalues are negative. Considering Equation (
23) we have,
Comparing Equations (
24) and (
16), we can conclude that
and since the basic reproductive number
and
for
implies that
is locally asymptotically stable. □
4.1.2. Local Stability of Virus Endemic Point
In this section, we investigate the stability of the Virus Endemic Equilibrium Point(VEE) to see if a small change around it will cause a drastic change or effect on the model or will cause it to return to its original state. In this model, we consider two-state endemic points and investigate their stability. We prove this by showing that by the theorem below.
Theorem 5. The VEE of the system (5) is locally asymptotically stable whenever and unstable whenever Proof. We proceed by substituting
into (
22), to obtain
The characteristic equation of matrix
is
where
with
If
,
and
then
and
are all non-negative. By the Routh–Hurwitz criterion [
19], we can conclude that the endemic equilibrium point
is locally asymptotically stable. □
Theorem 6. If , then is unstable and stable when and a unique endemic equilibrium exist and are locally asymptotically stable in the interior of Ω with
Proof. We also evaluate the Jacobian matrix (
22) at the endemic state
. We have that
The characteristic equation of matrix
is
where
with
If
,
and
which implies that
and
are all non-negative. Then by Routh–Hurwitz criterion [
19], the endemic equilibrium point
is locally asymptotically stable. □
4.2. Global Stability Analysis
To obtain the global stability of the equilibrium points, we use the Ulam–Hyers stability criteria. We show that the fractional model (
5) is both stable and generalized stable in the sense of Ulam–Hyers. We say
is a solution of
if and only if there exists
satisfying,
- 1.
,
- 2.
Note that any function satisfying (2) also satisfies the integral inequality given,
Definition 3. The fractional order model see (5) and equivalently (7) is Ulam–Hyers stable if there exist such that for every and for each satisfying (25), there exist a solution of the model see (5) with, Definition 4. The fractional order model (5) and (7) is said to be generalized Ulam–Hyers stability if there exists a continuous function with , such that, for each solution of (25), there exist a solution of the model (5) such that, The stability of the fractional-order model is now presented as follows;
Theorem 7. Let the hypothesis and result of Lemma 3 hold see (3), and . Then the fractional order model (5) and (7) is Ulam–Hyers stable and consequently generalized Ulam–Hyers stable. Proof. Let
X be a unique solution of (
7) guaranteed by theorem(3.3) see (3),
satisfies (
25) and recalling the expression for (
8), (
26) we have for
we have that,
From the above, we obtain
, where
We conclude that the proposed problem (
5) is both Ulam–Hyers and generalized Ulam–Hyers stable since
such that
□
4.2.1. Global Stability of VFE Point
Using a Lyapunov function, we demonstrate that the virus-free equilibrium point is globally asymptotically stable.
Theorem 8. The virus free equilibrium, is globally asymptotically stable if
Proof. Consider the Lyapunov function of the Goh–Volterra type,
where
The solution of the system (
5) is determined by the derivative of
as follows
By evaluating the above expression at the
, we obtain,
where we have assumed that
at
and
Therefore,
if
Furthermore, by the LaSalle’s invariance principle, the virus-free equilibrium point
is globally asymptotically stable. □
4.2.2. Global Stability of Virus EE Point
Finally, we investigate the global stability of the endemic equilibrium points.
Theorem 9. The virus EE, is globally asymptotically stable if
Proof. We consider a Lyapunov function,
where
By differentiating and evaluating at
we obtain
where
and
If
then
provided
. Hence,
is negative semi-definite, and by the LaSalle’s invariance principle [
20], the endemic equilibrium point,
is globally asymptotically stable. □
We prove the global stability of the second endemic equilibrium point.
Theorem 10. The virus EE, is globally asymptotically stable if
Proof. Again, we consider the Goh–Volterra type lyapunov function,
where
It follows that By differentiating and evaluating at
we obtain
where
and
If
then
provided
. Then by LaSalle’s invariance principle [
20], the endemic equilibrium point,
, is globally asymptotically stable. □